Ole Zelmer

Ole Zelmer

Auto-generated profile, based on publicly available information

Ole Zelmer

Medizinische Hochschule Hannover, Deutschland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2026 in Pneumologie
Verified
Journal Article
Closed access
OZOle Zelmer
Ole Zelmer
RIRené Abu Isneineh
René Abu Isneineh
BSBenjamin Seeliger
Benjamin Seeliger
CKChristian Kühn
Christian Kühn
SSSusanne Simon
Susanne Simon
JGJens Gottlieb
Jens Gottlieb
Extracorporeal membrane oxygenation (ECMO) is increasingly used as a bridging strategy to lung transplantation. Long-term outcomes in this specific patient population after lung transplantation remain incompletely described. We investigated age-dependent long-term outcomes in adult lung transplant candidates on waiting list while receiving ECMO support. We performed a retrospective single-center cohort study including all adult patients listed for lung transplantation while receiving ECMO support between November 2010 and May 2025. Patients were stratified a priori by age at listing (<50 versus ≥50 years). The primary endpoint was 5-year post-transplant graft survival, defined as freedom from death or retransplantation. Secondary endpoints included comorbidities, frailty, exercise capacity, return to work, and patient-reported outcomes during outpatient follow-up. Among 1,493 patients listed for lung transplantation, 115 were listed while receiving ECMO support; 72 patients were aged <50 years and 43 patients were aged ≥50 years. Overall, 93 ECMO-listed patients (81%) underwent transplantation. One-, three-, and five-year post-transplant graft survival were 87%, 83%, and 77% in recipients aged <50 years compared with 72%, 53%, and 44% in recipients aged ≥50 years, respectively. Kaplan–Meier analysis demonstrated a significant difference between age groups. Recipient age ≥50 years was independently associated with an increased risk of graft loss in multivariable analysis (adjusted HR 2.53, 95% CI 1.14–5.59; p=0.022). Among patients reaching outpatient follow-up, older recipients had a slightly higher comorbidity burden, reduced exercise capacity, and lower rates of return to work, while Clinical Frailty Scale ≥4 remained relatively uncommon. In this 15-year single-center experience, recipient age ≥50 years was independently associated with inferior graft survival after ECMO-bridged lung transplantation. These findings support careful, function-oriented selection of older ECMO-supported candidates.